亚太再生医学市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

亚太再生医学市场按技术类型、应用(骨移植替代品、骨关节疾病、皮肤科、心血管、中枢神经系统和其他应用)和地理划分

市场快照

CAGR
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 21.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

干细胞技术是一项快速发展的技术,在再生医学中发挥着重要作用。它还服务于组织工程、发育细胞生物学、细胞疗法、基因疗法、化学生物学和纳米技术等学科。

干细胞提供了替代细胞和组织以治疗各种疾病和残疾的可能性,包括脊髓损伤、关节炎和帕金森病。此外,干细胞和基因治疗为疾病提供了潜在的治疗方法,而不是长期治疗,并将重点从治疗转向治疗。干细胞技术在疾病治疗中的应用最终提高了它们的采用率。因此,干细胞技术的日益普及以及研究的增加预计将在预测期内推动市场发展。

此外,在生物制剂、生物材料、干细胞技术和组织工程方面也有重大的技术进步,从而促进了市场的增长。

Scope of the report

As per the scope of the report, regenerative medicines are used to repair, replace, and regenerate the tissues and organs affected by injury, disease, or the natural aging process. These medicines restore the functionality of cells and tissues and are used in several degenerative disorders, such as dermatology, neurodegenerative diseases, cardiovascular, and orthopedic applications.

By Type of Technology
Stem Cell Therapy
Biomaterial
Tissue Engineering
Other Types of Technologies
By Application
Bone Graft Substitutes
Osteoarticular Diseases
Dermatology
Cardiovascular
Central Nervous System
Other Applications
Geography
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific

Report scope can be customized per your requirements. Click here.

主要市场趋势

预计皮肤科部门将在预测年份显示出更好的增长

根据应用,市场分为骨移植替代品、骨关节疾病、皮肤科、心血管、中枢神经系统和其他应用。皮肤科领域的高速增长归因于针对皮肤科伤口和疾病的简单移植技术的存在。

皮肤是测试再生医学新概念的有吸引力的模型器官之一,特别强调皮肤再生。每年都有越来越多的慢性伤口病例在增加。因此,组织工程皮肤替代物代表了治疗急性/慢性皮肤伤口的创新选择。生物工程皮肤替代品现在已成为主要生理功能的替代品,通过为缺陷提供快速可靠的覆盖,通过减少患者的疼痛和不适。因此,由于这些因素,预计该细分市场将在预测期内实现快速增长。

Asia-Pacific Regenerative Medicine Market 1

竞争格局

亚太再生医学市场的主要参与者是艾尔建公司、百特国际公司、Becton、Dickinson and Company、Cook Group Incorporated、Integra LifeSciences Corporation、Medtronic PLC、默克、Smith & Nephew plc 和 Thermo Fisher Scientific。因此,所有这些公司都在对新技术进行大量投资,从而推动了市场。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Technological Advancements in Regenerative Medicine

      2. 4.2.2 Increasing Adoption of Stem Cell Technology

      3. 4.2.3 Rising Government Initiatives

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Treatments

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type of Technology

      1. 5.1.1 Stem Cell Therapy

      2. 5.1.2 Biomaterial

      3. 5.1.3 Tissue Engineering

      4. 5.1.4 Other Types of Technologies

    2. 5.2 By Application

      1. 5.2.1 Bone Graft Substitutes

      2. 5.2.2 Osteoarticular Diseases

      3. 5.2.3 Dermatology

      4. 5.2.4 Cardiovascular

      5. 5.2.5 Central Nervous System

      6. 5.2.6 Other Applications

    3. 5.3 Geography

      1. 5.3.1 Asia-Pacific

        1. 5.3.1.1 China

        2. 5.3.1.2 Japan

        3. 5.3.1.3 India

        4. 5.3.1.4 Australia

        5. 5.3.1.5 South Korea

        6. 5.3.1.6 Rest of Asia-Pacific

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Allergan plc

      2. 6.1.2 Baxter International Inc.

      3. 6.1.3 Becton, Dickinson and Company

      4. 6.1.4 Cook Group Incorporated

      5. 6.1.5 Integra LifeSciences Corporation

      6. 6.1.6 Medtronic PLC

      7. 6.1.7 Merck KGaA

      8. 6.1.8 Smith & Nephew plc (Osiris Therapeutics)

      9. 6.1.9 Thermo Fisher Scientific

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Asia-Pacific Regenerative Medicine Market market is studied from 2018 - 2026.

The Asia-Pacific Regenerative Medicine Market is growing at a CAGR of 21.5% over the next 5 years.

Allergan plc, Cook Group Incorporated, Integra LifeSciences Corporation, Medtronic PLC, Smith & Nephew plc (Osiris Therapeutics) are the major companies operating in Asia-Pacific Regenerative Medicine Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!